NeuroProfile Competitors and Similar CompaniesClear all
Shionogi's competitors and similar companies include ACADIA Pharmaceuticals.
 Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. | |
Founding Date | Founding Date 1878 | Founding Date 1993 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations San Diego, US HQ Princeton, US |
Employees | Employees 4,955 | Employees 513 |
Valuation ($) | Valuation ($) 12.3 b | Valuation ($) 2.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $1.1b (FY, 2025) |
Cost of goods | Cost of goods ¥62.1b (FY, 2026) | Cost of goods $89m (FY, 2025) |
Gross profit | Gross profit ¥484.8b (FY, 2026) | Gross profit $982.5m (FY, 2025) |
Net income | Net income ¥205.9b (FY, 2026) | Net income $391m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 4.7m | Total funding raised $ 770.8m |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View company